1. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine. 2006;24:11-25.

https://doi.org/10.1016/j.vaccine.2006.05.111

PMid:16949997 

2. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2008;22:2675-86.

https://doi.org/10.1093/annonc/mdr015

PMid:21471563 

3. Bosch FX, Lorincz A, Muñoz N, Meijer, Shah KV. The causal realtion between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-65.

https://doi.org/10.1136/jcp.55.4.244

PMid:11919208 PMCid:PMC1769629

4. Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, Hedau S, et al. Infection of human papillomaviruses in cancers of different human organ sites. Indian J Med Res. 2009;130:222-33.

PMid:19901431

5. Muñoz N, Castellsagué X, de González AB, Grissman L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24:1-10.

https://doi.org/10.1016/j.vaccine.2006.05.115

PMid:16949995 

6. Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10:550-60.

https://doi.org/10.1038/nrc2886

PMid:20592731 

7. Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al. The biology and life-cycle of human papillomaviruses. Vaccine 2012;30:F55-70.

https://doi.org/10.1016/j.vaccine.2012.06.083

PMid:23199966 

8. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131:2349-59.

https://doi.org/10.1002/ijc.27485

PMid:22323075 

9. Rositch AF, Koshiol J, Hudgens MG, Razzaghi H, Backes DM, Pimenta JM, et al. Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysus. Int J Cancer. 2013;133:1271-85.

https://doi.org/10.1002/ijc.27828

PMid:22961444 PMCid:PMC3707974

10. Feller L, Wood NH, Khammissa RA, Lemmer J. Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma. Head Face Med. 2010;6:15.

https://doi.org/10.1186/1746-160X-6-15

PMid:20633288 PMCid:PMC2917403

11. Leichliter JS, Chandra A, Liddon N, Fenton KA, Aral SO. Prevalence and correlates of heterosexual anal and oral sex in adolescents and adults in the United States. J Infect Dis. 2007;196:1852-9.

https://doi.org/10.1086/522867

PMid:18190267 

12. Syrjänen S. The role of human papillomavirus infection in head and neck cancers. Ann Oncol. 2010;21:243-5.

https://doi.org/10.1093/annonc/mdq454

PMid:20943622 

13. Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussman JP, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003;104:336-44.

https://doi.org/10.1002/ijc.10960

PMid:12569557 

14. SahebJamee M, Boorghani M, Ghaffari SR, AtarbashiMoghadam F, Keyhani A. Human papillomavirus in saliva of patients with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2009;14:e525-8.

https://doi.org/10.4317/medoral.14.e525

PMid:19680210 

15. Martín-Hernán F, Sánchez-Hernández JG, Cano J, Campo J, del Romero J. Oral cancer, HPV infection and evidence of sexual transmission. Med Oral Patol Oral Cir Bucal. 2013;18:e439-44.

https://doi.org/10.4317/medoral.18419

PMid:23524417 PMCid:PMC3668870

16. D'Souza G, Sugar E, Ruby W, Gravitt P, Gillison M. Analysis of the effect of DNA purification on detection papillomavirus in oral rinse samples by PCR. J Clin Microbiol. 2015;43:5526-35.

https://doi.org/10.1128/JCM.43.11.5526-5535.2005

PMid:16272481 PMCid:PMC1287828

17. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38:357-61.

PMid:10618116

18. Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, et al. Determinants of genetical human papillomavirus detection in a US population. J Infect Dis. 2001;183:1554-64.

https://doi.org/10.1086/320696

PMid:11343204 

19. Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. FICO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000;70:209-62.

https://doi.org/10.1016/S0020-7292(00)90001-8

PMid:11041682

20. Adamopoulou M, Vairaktaris E, Nkenke E, Avgoustidis D, Karakitsos P, Sioulas V, et al. Prevalence of human papillomavirus in saliva and cérvix of sexually active women. Gynecol Oncol. 2013;129:395-400.

https://doi.org/10.1016/j.ygyno.2013.02.015

PMid:23428459 

21. Saini R, Khim TP, Rahman SA, Ismail M, tang TH. High-risk human papillomavirus in the oral cavity of women with cervical cancer, and their children. Virol J. 2010;7:131.

https://doi.org/10.1186/1743-422X-7-131

PMid:20550718 PMCid:PMC2901268

22. Visalli G, Currò M, Facciolà A, Riso R, Modello P, Laganà P, et al. Prevalence of human papillomavirus in saliva of women with HPV genital lesions. Infect Agent Cancer. 2016;11:48.

https://doi.org/10.1186/s13027-016-0096-3

PMid:27570540 PMCid:PMC5000464

23. Giraldo P, Gonçalves AK, Pereira SA, Barros-Mazon S, Gondo ML, Within SS, et al. Human papillomavirus in the oral mucosa of women with genital human papillomavirus lesions. Eur J Obstet Gynecol Reprod Biol. 2006;126:104-6.

https://doi.org/10.1016/j.ejogrb.2005.09.009

PMid:16324781 

24. Adamopoulou M, Vairaktaris E, Panis V, Nkenke E, Neukam FW, Yapijakis C. HPV detection rate in saliva may depend on the immune system efficiency. In Vivo. 2008;22:599-602.

PMid:18853753

25. Ragin C, Edwards R, Larkins-Pettigrew M, Taioli E, Eckstein S, Thurman N, et al. Oral HPV infection and sexuality: a cross-sectional study in women. Int J Mol Sci. 2011;12:3928-40.

https://doi.org/10.3390/ijms12063928

PMid:21747715 PMCid:PMC3131599

26. Schlecht NF, Burk RD, Nucci-Sack A, Shankar V, Peake K, Lorde-Rollins E, et al. Cervical, anal and oral HPV in an adolescent inner-city health clinic providing free vaccinations. PLoS One. 2012;7:e37419.

https://doi.org/10.1371/journal.pone.0037419

PMid:22624027 PMCid:PMC3356254

27. Sayya-Melli M, Kazemi-Sheshvan, Bondayi M, Ouladsahebmadarek E, Dasranj-Tabrizi A, Ghojazadeh M, et al. Saudi Med J. 2011;32:141-6.

PMid:21301759

28. Vogt SL, Gravitt PE, Martinson NA, Hoffmann J, D'Souza G. Concordant Oral-Genital HPV Infection in South Africa Couples: Evidence for Transmission. Front Oncol. 2013;3:303.

https://doi.org/10.3389/fonc.2013.00303

PMid:24377087 PMCid:PMC3860183

29. Smith EM, Ritchie JM, Yankowitz J, Wang D, Turek LP, Haugen TH. HPV prevalence and concordance in the cervix and oral cavity of pregnant women. Infect Dis Obstet Gynecol. 2004;12:45-56.

https://doi.org/10.1080/10647440400009896

PMid:15739817 PMCid:PMC1784596

30. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol. 1993;82:578-85.

https://doi.org/10.1097/00006250-199310000-00021

PMid:8397358